Cubist Systematic Strategies’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Cubist Systematic Strategies’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,926	Closed	-$808K	–	2806
2020 Q3	$808K	Sell	5,926 -15,607	-72%	-$1.66M	0.01%	1461
2020 Q2	$2.08M	Buy	21,533 +9,176	+74%	+$765K	0.04%	771
2020 Q1	$579K	Buy	12,357 +1,759	+17%	+$113K	0.02%	1162
2019 Q4	$772K	Buy	10,598 +770	+8%	+$46.7K	0.01%	1314
2019 Q3	$513K	Sell	9,828 -11,942	-55%	-$635K	0.01%	1278
2019 Q2	$1.09M	Buy	+21,770	New	+$1.06M	0.02%	994
2018 Q4	–	Sell	-3,066	Closed	-$200K	–	2377
2018 Q3	$200K	Buy	+3,066	New	+$180K	0.01%	1415
2018 Q2	–	Sell	-6,175	Closed	-$301K	–	2160
2018 Q1	$301K	Buy	+6,175	New	+$321K	0.02%	1150
2017 Q4	–	Sell	-8,281	Closed	-$355K	–	2180
2017 Q3	$355K	Buy	+8,281	New	+$264K	0.02%	1044

Cubist Systematic Strategies's MYOK Position: Q4 2020 in Review

Cubist Systematic Strategies sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 5,926 shares — an estimated $808K sold.

Cubist Systematic Strategies first reported a position in MYOK in Q3 2017 and held it in 9 quarters. The position peaked at $2.08M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Cubist Systematic Strategies reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Cubist Systematic Strategies sold 5,926 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $808K.
Cubist Systematic Strategies first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
Cubist Systematic Strategies's MyoKardia, Inc. Common Stock position peaked at $2.08M in Q2 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Cubist Systematic Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.